10 20 30 40 50 60 70 80 2WEC - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER HYDROLASE 03-FEB-98 2WEC
TITLE ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX TITLE 2 WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1- TITLE 3 NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY TITLE 4 PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENICILLOPEPSIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.23.20
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PENICILLIUM JANTHINELLUM; SOURCE 3 ORGANISM_TAXID: 5079
KEYWDS PENICILLOPEPSIN, PHOSPHONATE INHIBITOR, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR J.DING,M.E.FRASER,M.N.G.JAMES
REVDAT 2 24-FEB-09 2WEC 1 VERSN REVDAT 1 27-MAY-98 2WEC 0
SPRSDE 27-MAY-98 2WEC 1WEC
JRNL AUTH J.DING,M.E.FRASER,J.H.MEYER,P.A.BARTLETT, JRNL AUTH 2 M.N.G.JAMES JRNL TITL MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN. II. JRNL TITL 2 X-RAY CRYSTALLOGRAPHIC ANALYSES OF PENICILLOPEPSIN JRNL TITL 3 COMPLEXED WITH A P3-P1 MACROCYCLIC PEPTIDYL JRNL TITL 4 INHIBITOR AND WITH ITS TWO ACYCLIC ANALOGUES JRNL REF J.AM.CHEM.SOC. V. 120 4610 1998 JRNL REFN ISSN 0002-7863
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.H.MEYER,P.A.BARTLETT REMARK 1 TITL MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN. I. REMARK 1 TITL 2 DESIGN, SYNTHESIS, AND EVALUATION OF AN INHIBITOR REMARK 1 TITL 3 BRIDGED BETWEEN P1 AND P3 REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH M.E.FRASER,N.C.STRYNADKA,P.A.BARTLETT,J.E.HANSON, REMARK 1 AUTH 2 M.N.JAMES REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE REMARK 1 TITL 2 MIMICS BOUND TO PENICILLOPEPSIN: REMARK 1 TITL 3 PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES REMARK 1 REF BIOCHEMISTRY V. 31 5201 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.N.JAMES,A.R.SIELECKI,K.HAYAKAWA,M.H.GELB REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE REMARK 1 TITL 2 MIMICS BOUND TO PENICILLOPEPSIN: REMARK 1 TITL 3 DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING REMARK 1 TITL 4 PEPTIDES REMARK 1 REF BIOCHEMISTRY V. 31 3872 1992 REMARK 1 REFN ISSN 0006-2960
REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT V. 5-E, X-PLOR REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.0 REMARK 3 NUMBER OF REFLECTIONS : 35565 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.147 REMARK 3 R VALUE (WORKING SET) : 0.141 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1580 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1520 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 39118 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2374 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 338 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 12.872 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.010 ; 1.100 ; 2497 REMARK 3 BOND ANGLES (DEGREES) : 1.345 ; 1.100 ; 3387 REMARK 3 TORSION ANGLES (DEGREES) : 15.315; 5.000 ; 1405 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.011 ; 2.000 ; 68 REMARK 3 GENERAL PLANES (A) : 0.016 ; 5.000 ; 366 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 6.145 ; 0.005 ; 2497 REMARK 3 NON-BONDED CONTACTS (A) : 0.019 ; 9.000 ; 27 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.87 REMARK 3 BSOL : 314.20 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : CSDX_PROTGEO.DAT, OTHERGEO.DAT, PP5GEO.DAT, REMARK 3 SEMTHMGEO.DAT, CONTACT.DAT REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: X-PLOR AND TNT ESD FROM SIGMAA (A) : REMARK 3 0.189043 UNCERTAINTY IN RMS ERROR SQUARED : 0.005075
REMARK 4 REMARK 4 2WEC COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAY-97 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 4.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ROTATING ANODE GENER WITH REMARK 200 COPPER TARGET REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XENGEN REMARK 200 DATA SCALING SOFTWARE : XENGEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39118 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 37.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 5.260 REMARK 200 R MERGE (I) : 0.08910 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 27.2800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.30400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 METHOD REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NAC2H3O2 PH=4.4 35-40% REMARK 280 SATURATED (NH4)2SO4
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.62000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.31500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.62000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.31500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 68.42651 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 59.23377
REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 520 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 677 LIES ON A SPECIAL POSITION.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 13 18.80 59.45 REMARK 500 THR A 62 -12.79 -144.39 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 443 DISTANCE = 6.16 ANGSTROMS REMARK 525 HOH A 449 DISTANCE = 7.82 ANGSTROMS REMARK 525 HOH A 491 DISTANCE = 9.05 ANGSTROMS REMARK 525 HOH A 495 DISTANCE = 5.53 ANGSTROMS REMARK 525 HOH A 504 DISTANCE = 5.72 ANGSTROMS REMARK 525 HOH A 516 DISTANCE = 5.26 ANGSTROMS REMARK 525 HOH A 534 DISTANCE = 7.39 ANGSTROMS REMARK 525 HOH A 535 DISTANCE = 10.54 ANGSTROMS REMARK 525 HOH A 538 DISTANCE = 9.95 ANGSTROMS REMARK 525 HOH A 540 DISTANCE = 6.66 ANGSTROMS REMARK 525 HOH A 549 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH A 556 DISTANCE = 5.58 ANGSTROMS REMARK 525 HOH A 564 DISTANCE = 5.72 ANGSTROMS REMARK 525 HOH A 565 DISTANCE = 5.35 ANGSTROMS REMARK 525 HOH A 568 DISTANCE = 5.62 ANGSTROMS REMARK 525 HOH A 574 DISTANCE = 7.23 ANGSTROMS REMARK 525 HOH A 583 DISTANCE = 5.03 ANGSTROMS REMARK 525 HOH A 585 DISTANCE = 7.15 ANGSTROMS REMARK 525 HOH A 587 DISTANCE = 7.66 ANGSTROMS REMARK 525 HOH A 592 DISTANCE = 7.49 ANGSTROMS REMARK 525 HOH A 593 DISTANCE = 9.25 ANGSTROMS REMARK 525 HOH A 594 DISTANCE = 11.56 ANGSTROMS REMARK 525 HOH A 596 DISTANCE = 6.80 ANGSTROMS REMARK 525 HOH A 600 DISTANCE = 6.59 ANGSTROMS REMARK 525 HOH A 613 DISTANCE = 5.62 ANGSTROMS REMARK 525 HOH A 622 DISTANCE = 5.03 ANGSTROMS REMARK 525 HOH A 623 DISTANCE = 7.59 ANGSTROMS REMARK 525 HOH A 624 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH A 625 DISTANCE = 8.71 ANGSTROMS REMARK 525 HOH A 626 DISTANCE = 6.01 ANGSTROMS REMARK 525 HOH A 630 DISTANCE = 9.58 ANGSTROMS REMARK 525 HOH A 631 DISTANCE = 11.48 ANGSTROMS REMARK 525 HOH A 634 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH A 648 DISTANCE = 5.21 ANGSTROMS REMARK 525 HOH A 654 DISTANCE = 7.22 ANGSTROMS REMARK 525 HOH A 660 DISTANCE = 8.34 ANGSTROMS REMARK 525 HOH A 661 DISTANCE = 8.79 ANGSTROMS REMARK 525 HOH A 662 DISTANCE = 9.12 ANGSTROMS REMARK 525 HOH A 665 DISTANCE = 7.13 ANGSTROMS REMARK 525 HOH A 668 DISTANCE = 6.76 ANGSTROMS REMARK 525 HOH A 669 DISTANCE = 8.29 ANGSTROMS REMARK 525 HOH A 671 DISTANCE = 7.94 ANGSTROMS REMARK 525 HOH A 672 DISTANCE = 6.60 ANGSTROMS REMARK 525 HOH A 676 DISTANCE = 6.09 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CIC REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE. REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAN A 324 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAN A 325 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 339 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PP5 A 326
DBREF 2WEC A 1 323 UNP P00798 PENP_PENJA 1 323
SEQRES 1 A 323 ALA ALA SER GLY VAL ALA THR ASN THR PRO THR ALA ASN SEQRES 2 A 323 ASP GLU GLU TYR ILE THR PRO VAL THR ILE GLY GLY THR SEQRES 3 A 323 THR LEU ASN LEU ASN PHE ASP THR GLY SER ALA ASP LEU SEQRES 4 A 323 TRP VAL PHE SER THR GLU LEU PRO ALA SER GLN GLN SER SEQRES 5 A 323 GLY HIS SER VAL TYR ASN PRO SER ALA THR GLY LYS GLU SEQRES 6 A 323 LEU SER GLY TYR THR TRP SER ILE SER TYR GLY ASP GLY SEQRES 7 A 323 SER SER ALA SER GLY ASN VAL PHE THR ASP SER VAL THR SEQRES 8 A 323 VAL GLY GLY VAL THR ALA HIS GLY GLN ALA VAL GLN ALA SEQRES 9 A 323 ALA GLN GLN ILE SER ALA GLN PHE GLN GLN ASP THR ASN SEQRES 10 A 323 ASN ASP GLY LEU LEU GLY LEU ALA PHE SER SER ILE ASN SEQRES 11 A 323 THR VAL GLN PRO GLN SER GLN THR THR PHE PHE ASP THR SEQRES 12 A 323 VAL LYS SER SER LEU ALA GLN PRO LEU PHE ALA VAL ALA SEQRES 13 A 323 LEU LYS HIS GLN GLN PRO GLY VAL TYR ASP PHE GLY PHE SEQRES 14 A 323 ILE ASP SER SER LYS TYR THR GLY SER LEU THR TYR THR SEQRES 15 A 323 GLY VAL ASP ASN SER GLN GLY PHE TRP SER PHE ASN VAL SEQRES 16 A 323 ASP SER TYR THR ALA GLY SER GLN SER GLY ASP GLY PHE SEQRES 17 A 323 SER GLY ILE ALA ASP THR GLY THR THR LEU LEU LEU LEU SEQRES 18 A 323 ASP ASP SER VAL VAL SER GLN TYR TYR SER GLN VAL SER SEQRES 19 A 323 GLY ALA GLN GLN ASP SER ASN ALA GLY GLY TYR VAL PHE SEQRES 20 A 323 ASP CYS SER THR ASN LEU PRO ASP PHE SER VAL SER ILE SEQRES 21 A 323 SER GLY TYR THR ALA THR VAL PRO GLY SER LEU ILE ASN SEQRES 22 A 323 TYR GLY PRO SER GLY ASP GLY SER THR CYS LEU GLY GLY SEQRES 23 A 323 ILE GLN SER ASN SER GLY ILE GLY PHE SER ILE PHE GLY SEQRES 24 A 323 ASP ILE PHE LEU LYS SER GLN TYR VAL VAL PHE ASP SER SEQRES 25 A 323 ASP GLY PRO GLN LEU GLY PHE ALA PRO GLN ALA
MODRES 2WEC SER A 3 SER GLYCOSYLATION SITE MODRES 2WEC THR A 7 THR GLYCOSYLATION SITE
HET MAN A 324 11 HET MAN A 325 11 HET SO4 A 339 5 HET PP5 A 326 38
HETNAM MAN ALPHA-D-MANNOSE HETNAM SO4 SULFATE ION HETNAM PP5 METHYL (2S)-[1-((N-(NAPHTHALENEACETYL))-L-VALYL) HETNAM 2 PP5 AMINOMETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYL PROPANOATE
FORMUL 2 MAN 2(C6 H12 O6) FORMUL 4 SO4 O4 S 2- FORMUL 5 PP5 C28 H32 N2 O7 P 1- FORMUL 6 HOH *338(H2 O)
HELIX 1 1 ALA A 12 ASP A 14 5 3 HELIX 2 2 ALA A 48 GLN A 51 1 4 HELIX 3 3 PRO A 59 THR A 62 1 4 HELIX 4 4 ALA A 110 GLN A 114 1 5 HELIX 5 5 SER A 127 ILE A 129 5 3 HELIX 6 6 PHE A 140 SER A 147 1 8 HELIX 7 7 SER A 172 LYS A 174 5 3 HELIX 8 8 ASP A 223 GLN A 232 1 10 HELIX 9 9 GLY A 269 ILE A 272 1 4 HELIX 10 10 ASP A 300 SER A 305 1 6
SHEET 1 A 4 ILE A 18 ILE A 23 0 SHEET 2 A 4 THR A 26 ASP A 33 -1 N LEU A 30 O THR A 19 SHEET 3 A 4 GLY A 120 GLY A 123 1 N LEU A 122 O ASN A 31 SHEET 4 A 4 LEU A 39 VAL A 41 -1 N TRP A 40 O LEU A 121 SHEET 1 B 3 THR A 70 SER A 74 0 SHEET 2 B 3 SER A 80 ASP A 88 -1 N GLY A 83 O TRP A 71 SHEET 3 B 3 GLN A 100 ILE A 108 -1 N GLN A 107 O SER A 82 SHEET 1 C 2 VAL A 90 VAL A 92 0 SHEET 2 C 2 VAL A 95 ALA A 97 -1 N ALA A 97 O VAL A 90 SHEET 1 D 5 VAL A 164 PHE A 167 0 SHEET 2 D 5 LEU A 152 ALA A 156 -1 N ALA A 156 O VAL A 164 SHEET 3 D 5 GLN A 306 ASP A 311 -1 N PHE A 310 O PHE A 153 SHEET 4 D 5 GLN A 316 PRO A 321 -1 N ALA A 320 O TYR A 307 SHEET 5 D 5 THR A 180 GLY A 183 -1 N THR A 182 O LEU A 317 SHEET 1 E 3 SER A 192 VAL A 195 0 SHEET 2 E 3 PHE A 208 ALA A 212 -1 N GLY A 210 O PHE A 193 SHEET 3 E 3 SER A 296 PHE A 298 1 N SER A 296 O ILE A 211 SHEET 1 F 4 GLN A 203 ASP A 206 0 SHEET 2 F 4 SER A 197 ALA A 200 -1 N ALA A 200 O GLN A 203 SHEET 3 F 4 PHE A 256 ILE A 260 -1 N SER A 259 O SER A 197 SHEET 4 F 4 TYR A 263 VAL A 267 -1 N VAL A 267 O PHE A 256 SHEET 1 G 2 LEU A 219 LEU A 221 0 SHEET 2 G 2 ILE A 287 SER A 289 1 N GLN A 288 O LEU A 219 SHEET 1 H 4 GLN A 237 ASP A 239 0 SHEET 2 H 4 GLY A 244 ASP A 248 -1 N VAL A 246 O GLN A 237 SHEET 3 H 4 THR A 282 GLY A 285 -1 N CYS A 283 O PHE A 247 SHEET 4 H 4 ASN A 273 PRO A 276 -1 N GLY A 275 O LEU A 284
SSBOND 1 CYS A 249 CYS A 283 1555 1555 2.04
LINK C1 MAN A 324 OG SER A 3 1555 1555 1.40 LINK C1 MAN A 325 OG1 THR A 7 1555 1555 1.39
CISPEP 1 GLN A 133 PRO A 134 0 1.36 CISPEP 2 GLY A 314 PRO A 315 0 -4.12
SITE 1 CIC 2 ASP A 33 ASP A 213 SITE 1 AC1 11 SER A 3 THR A 9 PRO A 10 THR A 11 SITE 2 AC1 11 GLN A 160 GLN A 161 PRO A 162 HOH A 385 SITE 3 AC1 11 HOH A 523 HOH A 542 HOH A 572 SITE 1 AC2 6 THR A 7 GLN A 150 HOH A 495 HOH A 577 SITE 2 AC2 6 HOH A 595 HOH A 675 SITE 1 AC3 4 TYR A 175 SER A 178 LEU A 179 HOH A 608 SITE 1 AC4 16 GLU A 15 TYR A 75 GLY A 76 ASP A 77 SITE 2 AC4 16 ASP A 213 GLY A 215 THR A 216 THR A 217 SITE 3 AC4 16 LEU A 218 ALA A 242 GLY A 243 HOH A 364 SITE 4 AC4 16 HOH A 389 HOH A 442 HOH A 651 HOH A 663
CRYST1 97.240 46.630 65.870 90.00 115.94 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010284 0.000000 0.005002 0.00000
SCALE2 0.000000 0.021445 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016882 0.00000